Aspire Biopharma(Asbp) Financials: Payables Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - payables turnover
This chart shows the historical trend of payables turnover for ASBP compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Payables Turnover
Definition: Payables turnover shows how fast the company pays its suppliers for goods or services bought on credit. A high turnover means the company pays suppliers quickly, which may reflect strong cash flow or favorable terms. A very low turnover might mean the company is stretching payments to preserve cash — or possibly experiencing financial strain.
Interpretation:
• In '2022', ASBP's payables turnover was 0.00, indicating how promptly the company pays its suppliers. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 1.99.
• In '2023', ASBP's payables turnover was 0.00, indicating how promptly the company pays its suppliers. The figure remained stable compared to '2022'. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.93. Industry average declined by 0.05 from previous year.
Overall, ASBP's payables turnover has remained generally stable over the past 2 years.
Formula: Payables Turnover = Cost of Goods Sold / Average Accounts Payable
Good Range: Ranges 5-15 depending on industry.